113 related articles for article (PubMed ID: 9754943)
1. The 5-HT1A receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis.
Suchanek B; Struppeck H; Fahrig T
Eur J Pharmacol; 1998 Aug; 355(1):95-101. PubMed ID: 9754943
[TBL] [Abstract][Full Text] [Related]
2. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702.
Ahlemeyer B; Beier H; Semkova I; Schaper C; Krieglstein J
Brain Res; 2000 Mar; 858(1):121-8. PubMed ID: 10700604
[TBL] [Abstract][Full Text] [Related]
3. The 5-HT1A receptor agonist Bay x 3702 inhibits apoptosis induced by serum deprivation in cultured neurons.
Ahlemeyer B; Glaser A; Schaper C; Semkova I; Krieglstein J
Eur J Pharmacol; 1999 Apr; 370(2):211-6. PubMed ID: 10323272
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of 5-HT1A receptor agonist, Bay X 3702, demonstrated in vitro and in vivo.
Semkova I; Wolz P; Krieglstein J
Eur J Pharmacol; 1998 Oct; 359(2-3):251-60. PubMed ID: 9832397
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.
De Vry J; Jentzsch KR
Eur J Pharmacol; 1998 Sep; 357(1):1-8. PubMed ID: 9788767
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
7. Oral post-lesion administration of 5-HT(1A) receptor agonist repinotan hydrochloride (BAY x 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis.
Harkany T; Mulder J; Horvath KM; Keijser J; van der Meeberg EK; Nyakas C; Luiten PG
Neuroscience; 2001; 108(4):629-42. PubMed ID: 11738499
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.
Mauler F; Fahrig T; Horváth E; Jork R
Brain Res; 2001 Jan; 888(1):150-157. PubMed ID: 11146061
[TBL] [Abstract][Full Text] [Related]
9. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of 5-HT(1A) receptors reduces apoptosis after transient forebrain ischemia in the rat.
Schaper C; Zhu Y; Kouklei M; Culmsee C; Krieglstein J
Brain Res; 2000 Nov; 883(1):41-50. PubMed ID: 11063986
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats.
Koyama T; Nakajima Y; Fujii T; Kawashima K
Neurosci Lett; 1999 Apr; 265(1):33-6. PubMed ID: 10327199
[TBL] [Abstract][Full Text] [Related]
12. In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release.
Casanovas JM; Berton O; Celada P; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):248-54. PubMed ID: 10997727
[TBL] [Abstract][Full Text] [Related]
13. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
[TBL] [Abstract][Full Text] [Related]
14. The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats.
Kline AE; Yu J; Horváth E; Marion DW; Dixon CE
Neuroscience; 2001; 106(3):547-55. PubMed ID: 11591455
[TBL] [Abstract][Full Text] [Related]
15. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
Dupuis DS; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
[TBL] [Abstract][Full Text] [Related]
16. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
17. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.
Johansson L; Sohn D; Thorberg SO; Jackson DM; Kelder D; Larsson LG; Rényi L; Ross SB; Wallsten C; Eriksson H; Hu PS; Jerning E; Mohell N; Westlind-Danielsson A
J Pharmacol Exp Ther; 1997 Oct; 283(1):216-25. PubMed ID: 9336327
[TBL] [Abstract][Full Text] [Related]
18. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
Alper RH; Nelson DL
Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
[TBL] [Abstract][Full Text] [Related]
19. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; de Montigny C; Blier P
J Pharmacol Exp Ther; 1998 Sep; 286(3):1239-47. PubMed ID: 9732384
[TBL] [Abstract][Full Text] [Related]
20. Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.
Xu L; Anwyl R; De Vry J; Rowan MJ
Eur J Pharmacol; 1997 Mar; 323(1):59-68. PubMed ID: 9105877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
